News
Gujarat Themis Biosyn standalone net profit declines 9.25% in the March 2026 quarter
25-May-2026 | 17:03
Sales rise 17.20% to Rs 44.23 crore
Net profit of Gujarat Themis Biosyn declined 9.25% to Rs 10.89 crore in the quarter ended March 2026 as against Rs 12.00 crore during the previous quarter ended March 2025. Sales rose 17.20% to Rs 44.23 crore in the quarter ended March 2026 as against Rs 37.74 crore during the previous quarter ended March 2025.
For the full year,net profit declined 4.29% to Rs 46.68 crore in the year ended March 2026 as against Rs 48.77 crore during the previous year ended March 2025. Sales rose 9.96% to Rs 165.82 crore in the year ended March 2026 as against Rs 150.80 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 44.23 | 37.74 | 17 | 165.82 | 150.80 | 10 |
| OPM % | 43.79 | 42.50 | - | 45.55 | 45.65 | - |
| PBDT | 18.38 | 17.32 | 6 | 75.01 | 70.91 | 6 |
| PBT | 14.34 | 16.09 | -11 | 62.09 | 65.54 | -5 |
| NP | 10.89 | 12.00 | -9 | 46.68 | 48.77 | -4 |
Powered by Capital Market - Live News
